// startup autopsy

IMD Health

Canada's physician platform built on pharma ad revenue — a foundation that regulators dissolved.

regulationRegulatory Kill

Forced closure by regulatory action

Founded	2009
Closed	2020
Country	Canada
Sector	Healthtech
Founder	Bruce Rigal

// the model, blind

Evaluating only IMD Health’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Regulation.

Key Events Timeline

2009

FOUNDING

Bruce Rigal founded IMD Health in Toronto to deliver clinical content and continuing medical education to Canadian physicians.

2015

PRODUCT LAUNCH

Launched tablet-based waiting room patient education system deployed in 3,000+ physician offices nationally.

2018

REGULATORY ACTION

Health Canada issued new guidelines restricting pharmaceutical company sponsorship of physician-facing digital platforms.

2020

SHUTDOWN

Pharma ad revenue declined 60%+; failed pivot to subscription model; ceased operations; assets sold to Stericycle.

Full Analysis

Free · no account needed

Documented cause

IMD Health offered a physician engagement platform providing clinical content and patient education tools to Canadian doctors, reaching 45,000 physician users at its peak. The company depended heavily on pharmaceutical advertising revenue, which collapsed after Health Canada tightened direct-to-physician marketing rules in 2018-2019. With ad revenue down over 60%, the company could not pivot to subscription SaaS quickly enough and ceased operations in 2020, with some assets absorbed by Stericycle.

Lesson

“Healthcare platforms relying on pharmaceutical ad revenue face existential risk from evolving marketing regulations.”

Failure anatomy

Collapse type

Regulatory Kill

📉 MEDIUM